Developing globally-accessible medicines for pandemic preparedness: An analysis of three alternative innovation models.
Sign Up to like & getrecommendations! Published in 2025 at "Global public health"
DOI: 10.1080/17441692.2025.2522173
Abstract: ABSTRACT Recent infectious disease crises (e.g. COVID-19, Ebola, mpox) show that the mainstream market-driven innovation model cannot ensure both rapid innovation and equitable global access to vaccines, drugs, and diagnostics critical for pandemic preparedness and… read more here.
Keywords: pandemic preparedness; innovation; global access; innovation models ... See more keywords
Alternative Pharmaceutical Innovation Models in Competitive Markets: A Collaborative Approach to Develop a Novel Drug for Hepatitis C
Sign Up to like & getrecommendations! Published in 2024 at "Tropical Medicine and Infectious Disease"
DOI: 10.3390/tropicalmed9100233
Abstract: Alternative innovation models have emerged to address failures of the traditional pharmaceutical system, particularly for diseases where market incentives do not attract sufficient research and development efforts. However, the feasibility of such models for diseases… read more here.
Keywords: innovation models; novel drug; medicine; hepatitis ... See more keywords